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Abstract
Background The estimation of physiologic ability and
surgical stress (E-PASS) has been used to produce a
numerical estimate of expected mortality and morbidity
after elective gastrointestinal surgery. The aim of this study
was to validate E-PASS in a selected cohort of patients
requiring liver resections (LR).
Methods In this retrospective study, E-PASS predictor
equations for morbidity and mortality were applied to the
prospective data from 243 patients requiring LR. The
observed rates were compared with predicted rates
using Fisher’s exact test. The discriminative capability of
E-PASS was evaluated using receiver-operating charac-
teristic (ROC) curve analysis.
Results The observed and predicted overall mortality
rates were both 3.3% and the morbidity rates were 31.3 and
26.9%, respectively. There was a significant difference in
the comprehensive risk scores for deceased and surviving
patients (p = 0.043). However, the scores for patients with
or without complications were not significantly different
(p = 0.120). Subsequent ROC curve analysis revealed a
poor predictive accuracy for morbidity.
Conclusions The E-PASS score seems to effectively
predict mortality in this specific group of patients but is a
poor predictor of complications. A new modified logistic
regression might be required for LR in order to better
predict the postoperative outcome.
Introduction
The quality of medical care is being increasingly judged by
hard facts and parameters that can be measured and com-
pared, including the length of hospital stay, in-hospital
mortality and morbidity, and the costs generated [1, 2]. If
potential postoperative problems can be predicted in
patient subgroups based on pre- and intraoperative mea-
sures, adequate preemptive steps can be taken to avoid
these complications. Mortality and morbidity are, if well
defined, readily measurable and objective parameters for
monitoring the standard of care within a center while
equally allowing for comparisons between different
centers.
The estimation of physiologic ability and surgical stress
(E-PASS) score was initially developed to predict adverse
postoperative effects in a study population of approxi-
mately 300 patients requiring elective gastrointestinal
surgery, ranging from laparoscopic cholecystectomy to
transthoracic esophagectomy [3]. Based on their E-PASS
score, patients are categorized into five groups, which then
allows for risk stratification of the expected morbidity and
mortality. The E-PASS score has already been validated
and shown to be reproducible by other authors, not only for
gastrointestinal surgery, but also for the elective repair of
abdominal aortic aneurysms, thoracic surgery, and osteo-
synthesis for hip fractures [4–7]. A possible advantage of
the E-PASS scoring system includes better overall assess-
ment that not only permits the evaluation of a patient’s
preoperative reserve capacities, but also allows for a con-
cise judgment of the surgical stress applied. Ideally, the
surgeon can make a rough preoperative estimate of how
much ‘‘surgical stress’’ the patient can tolerate in order to
obtain a low E-PASS score, which is associated with a low
expected morbidity and mortality.
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The aim of the current study was to review whether the
E-PASS scoring system could be used, without restrictions,
in hepatic surgery as a means of correctly predicting
morbidity and mortality.
Materials and methods
We carried out a retrospective analysis of prospective data
collected between January 2002 and December 2006 and
entered into a computer database system. All patients
requiring hepatic resection for benign or malignant condi-
tions treated in our unit were included for analysis.
Exclusion criteria included patients who were initially seen
for major hepatic surgery but only received liver biopsies
due to disseminated, inoperable disease. All patients
requiring emergency hepatic surgery were also excluded
from further analysis; they may already have met, to an
extent, the criteria for systemic inflammatory response
syndrome (SIRS) [8], possibly confounding the E-PASS
scores. The exclusion of patients requiring emergency
surgery was in accordance with the initial guidelines
developed by Haga et al. [3]. During the defined study
period, a total of 243 patients were included for E-PASS
analysis.
Postoperative complications were defined as all prob-
lems requiring medical, surgical, or other intervention and
treatment [9–11]. Documented general and liver-specific
complications included superficial infections in the form of
erythema or discharge requiring opening of the wound or
antibiotic therapy; deep infections in the form of intra-
abdominal collections or an abscess confirmed radiologi-
cally or at laparotomy; pulmonary embolus or thrombosis
confirmed radiologically by computed tomography or
duplex sonography; pneumonia determined by typical
clinical presentation, auscultatory findings, or positive
chest X-ray; delayed gastric emptying requiring the
placement of a nasogastric tube and intravenous fluids for
more than 1 week with delayed patient discharge and
hemorrhage or hematoma seen as a distinct drop in
hemoglobin values confirmed clinically, radiologically, or
at laparotomy; biliomas in the form of intra-abdominal
fluid collection with clearly elevated bilirubin values
requiring percutaneous drainage or surgical intervention.
Classification using the criteria of the American Society
of Anesthesiologists (ASA) was carried out by the
attending anesthetist in charge prior to surgery. The oper-
ation time was defined as the time from the first skin
incision to complete closure of all wounds. The E-PASS
scoring system was used retrospectively with the computer
database and supplemented by the patients’ medical files if
necessary, according to the defined criteria [3]. The com-
prehensive risk score (CRS) was calculated using the
E-PASS equations and includes the calculation of the
preoperative risk score (PRS) and the surgical stress score
(SSS) (Table 1). Patients were divided into one of five
groups [12] according to their final CRS: Group 1, CRS
\0; Group 2, 0 to \0.5; Group 3, 0.5 to \1.0; Group 4,
Table 1 Equations for calculating the E-PASS score [12]
Preoperative Risk Score (PRS)
-0.0686 ? 0.00345X1 ? 0.323X2 ? 0.205X3 ? 0.153X4 ? 0.148X5 ? 0.0666X6
X1 = age
X2 = presence (1) or absence (0) of severe heart disease
a
X3 = presence (1) or absence (0) of severe pulmonary disease
b
X4 = presence (1) or absence (0) of diabetes mellitus
c
X5 = performance status index (range = 0–4)
d
X6 = American Society of Anesthesiologists (ASA) classification (1-5)
Surgical Stress Score (SSS)
-0.342 ? 0.0139X1 ? 0.0392X2 ? 0.352X3
X1 = blood loss (ml)/body weight (kg)
X2 = operation time (h)
X3 = extent of skin incision; laparotomy plus thoracotomy (2), laparotomy (1), laparoscopy (0)
Comprehensive Risk Score (CRS)
-0.328 ? 0.936(PRS) ? 0.976(SSS)
a Severe heart disease as defined by the New York Heart Association Class III and IV or severe arrhythmia requiring mechanical support
b Severe pulmonary disease as defined by a vital capacity less than 60% and/or a forced expiratory volume of less than 50%
c Diabetes mellitus as defined by the World Health Organization criteria
d Performance status index as defined by the Eastern Cooperative Oncology Group (ECOG) criteria
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1.0 to \1.5; and Group 5, C1.5. Patients in Group 1 all
have a CRS value below zero, i.e., only negative CRS
numbers are included. Patients in Group 1 have the lowest
risk of postoperative complications or death, whereas
patients in Group 5 have the highest risk. Hospital mor-
tality was defined as death during the same admission as
the operation.
To avoid possible errors of observer-specific mistakes,
all data were independently checked and compared by two
staff members of our unit.
Statistical analysis
All variables were analyzed descriptively by the Fisher’s
exact test or Wilcoxon rank sum test; the Mann-Whitney
U test was used to examine differences in CRS distribu-
tion of patients with and without complications. The same
test was applied for the mortality group. Multivariate
analysis was performed using the multiple logistic
regression model. The ROC curves were plotted to assess
the extent to which CRS, PRS, and SSS can accurately
predict complications, where morbidity and mortality are
combined, and the area under the curve (AUC) was used
as a measure of overall diagnostic accuracy. A two-sided
exact binomial test was used to compare CRS group-
specific effective morbidity with expected morbidity. A p
value of less than 0.05 was taken to be significant. Sta-
tistical calculations were carried out using R version 2.5
and SAS version 9.1 software. All statistical analyses
were done with professional help from the Institute of
Mathematical Statistics and Actuarial Science, University
of Bern, Bern, Switzerland.
Results
Six of the initial 249 patients (2.4%) had to be excluded
from analysis because they either had incomplete data or
met SIRS criteria prior to surgery This resulted in a total of
243 patients receiving hepatic resections in our department
who were analyzed. Patient demographics and admission
data are summarized in Table 2. Table 3 lists the operative
procedures performed. One hundred eighty-eight (77.4%)
patients were operated on for malignant disease, with one
third requiring hepatic resection for colorectal liver
metastases (Table 4). Only a small percentage of our
patients underwent surgery for hepatocellular carcinoma,
with 21 patients (8.6%) of the total study population suf-
fering from cirrhosis.
Both the observed and predicted overall mortality rates
were 3.3% (8 and 8.03 patients, respectively); the observed
and predicted overall morbidity rates were 31.3% (76
patients) and 26.9% (65.4 patients), respectively. Overall
group-specific (Groups 1-5) predictive correlation was
good with a correlation coefficient of 0.96. Complications
were observed in 76 patients (Table 5) of which 10
(13.2%) required operative intervention, including four
abdominal lavages for biliomas and one for an abscess, one
revision for a biliary-cutaneous fistula and one for a
hematoma, one redo hepaticojejunostomy for persistent
biliary leakage, one closure of a small duodenal perfora-
tion, and one ileostomy for a colonic anastomotic leakage
in a patient who had received a combined liver and colon
segment resection. Of the eight deceased patients, five died
of multiple-organ failure, one of postoperative liver failure,
and two of acute cardiac failure.
Table 6 summarizes the mean CRS, PRS, and SSS
values for the study population, specifically comparing
those with and without mortality or morbidity. Expected
Table 2 Demographics of the 243 patients included in the E-PASS
study
Variable N (243)
Median age (range) (years) 61 (19-82)
Sex ratio (M:F) 131:112
ASA classification (I:II:III) 14:115:114
Mean (range) BMI (kg/m2) 24 (16.8-40.6)
Severe heart disease (%)a 32 (13.2)
Severe pulmonary disease (%)b 31 (12.8)
Diabetes mellitus (%)c 29 (11.9)
Observed hospital morbidity (%) 76 (31.3)
Observed hospital mortality (%) 8 (3.3)
Observed 30-day mortality (%) 6 (2.5)
ASA American Society of Anesthesiologists; BMI body mass index
a Severe heart disease as defined by the New York Heart Association
Class III and IV or severe arrhythmia requiring mechanical support
b Severe pulmonary disease as defined by a vital capacity less than
60%
c Diabetes mellitus as defined by the World Health Organisation
criteria
Table 3 Extent of liver resection in 243 patients
Type of hepatic resection N (%)
Hemihepatectomy left 17 (7)
Extended hemihepatectomy left 13 (5.4)
Hemihepatectomy right 62 (25.5)
Extended hemihepatectomy right 18 (7.4)
Atypical segmenta resection (C1) 23 (9.5)
Typical segmenta resection (C1) 106 (43.6)
Laparoscopic resection 4 (1.6)
C2 segmentsa 185 (76)
\2 segmentsa 58 (24)
a Liver segments are based on Couinaud’s classification
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morbidity (or mortality) was calculated by examining each
of the five possible CRS groups individually and multi-
plying the number of patients in each group (as observed in
this patient population) by the percentage probability of a
complication (or death) occurring according to the values
given by Haga’s study population [12].
As might be expected, deceased patients had a signifi-
cantly higher CRS than surviving patients (p = 0.043). The
CRS revealed no significant difference between the roun-
ded expected and observed in-hospital mortality
(p = 0.804), indicating that it might effectively predict the
outcome. However, there was no significant difference in
the CRS of patients with or without morbidity (p = 0.120).
The lack of power of CRS for predicting postoperative
complications is also demonstrated by the low AUC
(0.574) (Fig. 1a). Similar results were obtained by a sep-
arate analysis of PRS and SSS (Fig. 1b and c,
AUC = 0.521 and 0.571, respectively).
When comparing the group distribution of our 243
patients to that of the 5215 patients in Haga’s study pop-
ulation [12], our study population exhibits a highly
significant right shift (p \ 0.001), with more patients
belonging to a higher CRS group (Fig. 2). If group-specific
morbidity is evaluated, comparing actual, i.e., observed,
morbidity with expected morbidity (Table 7), we found
that significantly more patients in Group 2 (CRS 0 to\0.5)
have complications than would be expected (p = 0.001).
No other group had significant differences in observed and
expected morbidity.
To determine whether the PRS or SSS plays a more
important predictive role, we performed a multiple logistic
regression analysis with postoperative complications as the
dependent variable and PRS, SSS, and their interaction as
independent variables. Since the interaction term was not
significantly different from zero (p = 0.321), we estimated
Table 4 Indications for hepatic
resection
Underlying liver pathologies N = 243 (%) Patients with cirrhosis (Child score)
Colorectal liver metastases 78 (32.1) 1 (Child A)
Other liver metastases 40 (16.5) 0
Benign liver tumors 38 (15.6) 0
Cholangiocarcinoma 34 (14.0) 1 (Child A)
Hepatocellular carcinoma 24 (9.9) 19 (13 Child A, 6 Child B)
Echinococcal cysts 17 (7.0) 0
Other primary malignant tumors 12 (4.9) 0
Table 5 Postoperative complications requiring medical, surgical, or
other intervention
Type of complication N (%)a
Bilioma/ascites 36 (14.8)
Superficial infection 16 (6.6)
Pneumonia 11 (4.5)
Deep infection 10 (4.1)
Pulmonary embolus 8 (3.3)
Hemorrhage 7 (2.9)
Delayed gastric emptying 5 (2.1)
Deep vein thrombosis 2 (0.8)
Other (including myocardial infarction, percutaneous bile
fistula, duodenal perforation, leakage of colon
anastomosis, urosepsis, and portal vein thrombosis)
6 (2.5)
Number of complications 101
Number of patients with complications 76 (31.3)
Complications requiring operative intervention 10 (13.2)
a Out of a total 243 patients
Table 6 Summary of preoperative risk score (PRS), surgical stress
score (SSS), and comprehensive risk score (CRS) for liver resection
patients
Score Group N Mean (SD) p value*
PRS All patients 243 0.44 (0.20)
Mortality
Yes 8 0.54 (0.21) 0.150
No 235 0.44 (0.20)
Morbidity
Yes 76 0.44 (0.21) 0.866
No 158 0.44 (0.20)
SSS All patients 243 0.37 (0.29)
Mortality
Yes 8 0.50 (0.38) 0.477
No 235 0.36 (0.29)
Morbidity
Yes 76 0.42 (0.36) 0.090
No 158 0.34 (0.24)
CRS All patients 243 0.44 (0.34)
Mortality
Yes 8 0.67 (0.45) 0.043
No 235 0.44 (0.34)
Morbidity
Yes 76 0.50 (0.38) 0.120
No 158 0.41 (0.31)
* p values were calculated using the Wilcoxon signed-rank test.
Deceased patients were excluded from morbidity analysis. p \ 0.05
was considered significant
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a logistic regression model without interaction. In this
model, the PRS was not significantly different from zero
(p = 0.578); however, the SSS was a significant variable
(p = 0.022). In a third step, we used a model with SSS as
the only independent variable and it was still significant
(p = 0.021). Therefore, in the context of liver surgery, the
SSS plays a more important predictive role than the PRS.
Comparing the PRS and SSS of patients with or without
complications revealed no overall significant difference
(p = 0.866 and 0.090, respectively), but group-specific
comparisons showed a lack of fit for Groups 1, 2, and 4.
Discussion
This is the first time the E-PASS scoring system has been
applied to a specific hepatobiliary surgical patient popu-
lation. In our institution, the E-PASS system fails to
correctly predict patient outcome with respect to morbidity,
as demonstrated by the low AUC. If one breaks down the
E-PASS scoring system into the two separate contributors,
namely, the PRS and the SSS, the predictive strength of
either one is poor.
If mortality is looked at by itself, the CRS does seem to
correlate with the risk of death (p = 0.043). However,
these results need to be interpreted with caution because
the mortality rate corresponds to only eight patients,
resulting in a very small group for analysis. However, we
can show that the SSS seems to bear more weight than the
PRS. This would imply that surgical stress needs to be kept
to a minimum rather than exempting patients from further
surgery based solely on their preoperative status or PRS.
The authors of an initial E-PASS study also argued that the
SSS is potentially better correlated with postoperative
complications than the PRS, although this tended to be the
case only in younger patients [3].
With a postoperative morbidity rate of 31.3% and an in-
hospital mortality rate of 3.3%, our institution lies within
the accepted range of complications after hepatic resections
[13–15]. However, the risk of postoperative morbidity was
Fig. 1 Empirical receiver operating characteristic (ROC) curves to
assess the extent to which the comprehensive risk score (CRS),
preoperative risk score (PRS), and surgical stress score (SSS) can
accurately predict postoperative complications. The area under the
curve (AUC) is used as a measure of overall diagnostic accuracy. a
CRS does not accurately predict morbidity with a low AUC of 0.574.
b The AUC is very low (0.521), indicating that the PRS is poor in
predicting morbidity. c The AUC is 0.571, a low value, indicating the
poor predictive power of the SSS as far as morbidity is concerned
Fig. 2 The 243 patients from the current study compared to the study
population of 5212 patients from Haga et al. [12]. Our study
population shows a right-shift with significantly more patients in
higher CRS groups (p \ 0.001), indicating that our population
consisted of more high-risk patients. Group 1, CRS \0.0; Group 2,
CRS 0.0 to\0.5; Group 3, 0.5 to\1.0; Group 4, 1.0 to\1.5; Group 5,
[1.5. Note that \0.0 includes all CRS values below zero, i.e.,
negative numbers only
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underestimated with the E-PASS scoring system, particu-
larly for the CRS subgroup analysis. The 44 patients
(31.9%) with a CRS of zero to less than 0.5 had more
complications than would have been expected based on the
predicted rate (i.e., 28 patients, 20.4%).
It is evident that the risk of postoperative complications
or death is not solely determined by the surgeon’s technical
skills and his or her manual ability, but also by the patient’s
physiologic status, the underlying disease necessitating the
surgical intervention, and perioperative care [16]. It is the
combination of these factors that overtly influences the
final outcome. The difficulty lies in trying to determine
which patient tolerates which degree of surgical interven-
tion. In the future, this could influence the extent of surgery
and the selection of less invasive methods, especially for
patients with a high expected CRS ([1.0), who may be at a
greater risk for developing multiple-organ failure [17].
Although a surgeon’s instinct is important, obtaining
reproducible measures using a preoperative estimate of the
expected CRS, based on the calculated PRS and the esti-
mated range of SSS, will allow surgeons to more accurately
inform their patients of the potential risks prior to surgery.
This estimated preoperative SSS has to be based on per-
sonal experience and the average scores obtained from
previous similar interventions.
Haga et al. [3] based their initial findings on a very
heterogeneous group of patients, of which only a small
number (7.5%) underwent LR. Further studies validating
E-PASS either did not include hepatic surgery [4] or, again,
included only a small percentage of patients with LR [12].
We base our findings on a subgroup that underwent only
hepatic resection, with only very few selected patients
undergoing additional visceral resection. These two patient
populations were characterized by a significantly different
CRS distribution (p \ 0.001), with more of our patients
belonging to the higher CRS groups.
To minimize postoperative complications, many spe-
cialized liver centers currently use computerized
tomographic (CT) liver volume measurements to help
estimate remnant volume and combine these results with
the Child-Pugh score to maximize the assessment of pre-
operative liver function, which itself has been overtly
linked to postoperative liver failure and possible death [18,
19]. Other studies looked at a combination of the Child-
Pugh score with the indocyanine green retention test and
CT volumetry to best predict the short- and long-term
outcome after extended LR [20–22]. Although recent
findings possibly contradict the long-held belief that post-
operative liver failure is the main cause of mortality after
major LR, an assessment of preoperative liver function
remains the gold standard for patients requiring extensive
surgery or for those with varying degrees of cirrhotic liver
parenchyma [23]. One might argue that in this setting, the
E-PASS model does not take into account the complexity
and organ-specific problems unique to hepatic surgery.
Because our study population included only a very small
percentage (8.6%) of patients with cirrhosis, no statistically
significant differences were found when comparing the
reliability of E-PASS for patients with normal hepatic
function to that for patients with reduced hepatic function.
There have been numerous studies to develop audit tools
for a variety of surgical specialities, each one trying to
accommodate a specific setting [19, 24–30]. The overall
advantage of the E-PASS scoring system would seem to be
the relative ease with which data are acquired. No special
tests are required and intraoperative data collection is
limited to a few straightforward measurements. This is
favorable to, for example, the POSSUM or P-POSSUM
score, which requires 18 different variables compared with
the nine variables needed for the E-PASS score, making its
use in daily clinical practice tedious and impractical
[31, 32].
Other scoring models, such as the acute physiology and
chronic health evaluation (APACHE) II score used mainly
for patients in intensive care units, take into account only
physiologic factors and completely ignore the severity of
intraoperative stress. Furthermore, some of these scores,
such as the APACHE II score, date back to the mid-1980s
Table 7 Group-specific comparisons of expected and observed morbidity by comprehensive risk score (CRS)
CRS group Number of patients Expected morbiditya (%) Expected morbidity (n) Effective morbidity (n) p*
1 (\0) 12 4.5 1 1 0.425
2 (0 to \0.5) 138 20.4 28 44 0.001
3 (0.5 to \1.0) 75 40.2 30 27 0.482
4 (1.0 to \1.5) 6 66.7 4 2 0.100
5 (C1.5) 4 64.0 3 2 0.623
n = rounded patient numbers
a The expected morbidity was calculated by multiplying the effective patient number per CRS group by the expected percentage of morbidity
previously defined
* p values were calculated using a two-sided exact binomial test. Deceased patients were excluded from morbidity analysis [12]. p \ 0.05 was
taken as significant
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and the data obtained from this era may not be applicable
to the current standard of care [33]. Despite the relative
ease with which the E-PASS score can be used, such a
score is valuable only if it allows for the reliable acquisi-
tion of prognostic data.
In conclusion, the E-PASS scoring system has many
advantages such as simple evaluation steps involving easily
accessible data and the incorporation of preoperative
measurements with equally important intraoperative mea-
surements. The system has already been validated for use
in general gastrointestinal surgery and has exhibited a
correlation with expected and observed morbidity and
mortality. However, the E-PASS scoring system, within the
setting of hepatic surgery, cannot be used in its current
form and requires further evaluation and validation, with
possible adaptations of the original parameters to better fit
the postoperative predictions specific to liver surgery.
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